Primary Care Enhanced Services
Overview
Summary, notice description and lot information
The NHS Lincolnshire Integrated Care Board is planning to award a contract under the Provider Selection Regime for Primary Care Enhanced Services, which include phlebotomy, treatment room services, and specialised drug monitoring, among others. The procurement falls under the services category and is classified as general-practitioner services. The procurement method employed is limited, specifying an award procedure without prior publication of a call for competition.
Although the contract is yet to be formally awarded, it signifies an intention to award with a standstill period ending on 12th September 2025. Key decision criteria include quality, value, service integration, and social value, with a contract value estimated at £143,980 for the duration from 1st April 2025 to 31st March 2026, in the UKF3 region. This tender opportunity presents significant growth potential for businesses specialising in health care services, particularly those experienced in general-practitioner operations.
The procurement process is expected to benefit existing providers well-versed in primary care services capable of maintaining high standards across diverse offerings like safeguarding and DVT management. Small to medium-sized enterprises (SMEs), like St Peters Hill Surgery—cited as a potential supplier—are particularly well-positioned to compete, given their ability to deliver integrated, innovative care solutions efficiently under the guidelines of the Health Care Services Regulations 2023.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Leg Ulcer - Pessaries - Warfarin - DOAC - Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - DVT Assessment & Management including D-Dimer Testing
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Leg Ulcer - Pessaries - Warfarin - DOAC - Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - DVT Assessment & Management including D-Dimer Testing The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS143,980. The provider is an existing provider and the services are existing services.
Procurement Classification
Notice type, method, and CPV codes
Contract Values
Financial information and value estimates
Contract duration information not available.
Key Dates
Publication, submission, and award timeline
Notice Status
Current status of tender, lots, awards, and contracts
Contracting Authority
Buyer organisation and contact details
Awarded Supplier
Supplier who was awarded this contract
Documents & Links
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Need help with your tender submission?
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact UsBidding for contracts like this
Other tenders in North Kesteven
- Provision of Post Mortem and Mortuary Services 2023 - 2028 in Lincoln
- Specialist Substance Dependency Support for Victims of Domestic Abuse in Blaby
- AQP MRI Services in North Kesteven
- Transitional Care and Nursing Beds in Lincoln
- Education Psychology Services for Rutland County Council in Rutland
- Northamptonshire Ophthalmology Service in North Northamptonshire